Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Deirdre M. Mladsi, Amy L. Grogg, William D. Irish, Rebecca B. Lopez, Kathleen Degen, Alan Swann & Christian T. Nimsch. (2004) Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings. Current Medical Research and Opinion 20:12, pages 1883-1893.
Read now
Read now
Michael J. Burns. (2001) The Pharmacology and Toxicology of Atypical Antipsychotic Agents. Journal of Toxicology: Clinical Toxicology 39:1, pages 1-14.
Read now
Read now
Albert HC Wong, Suparna Sanyal, Mark GL Knapp & Hubert HM Van Tol. (1999) Potential therapeutic targets for schizophrenia. Emerging Therapeutic Targets 3:4, pages 571-586.
Read now
Read now
StevenB. Schwarzkopf, JohnF. Crilly & StevenM. Silverstein. (1999) Therapeutic Synergism: Optimal Pharmacotherapy and Psychiatric Rehabilitation to Enhance Functional Outcome in Schizophrenia. Psychiatric Rehabilitation Skills 3:1, pages 124-147.
Read now
Read now
Helen Dermatis, Marc Galanter, Susan Egelko & Laurence Westreich. (1998) Schizophrenic patients and cocaine use: Antecedents to hospitalization and course of treatment. Substance Abuse 19:4, pages 169-177.
Read now
Read now